Neurocrine Biosciences | 税前利润

Pre Tax Profit 更改 日
AbbVie USD 1.76B 4.24B 2024-03
Acadia Pharmaceuticals USD 21M 18.7M 2024-03
Agios Pharmaceuticals USD -81549000 14.39M 2024-03
ALKERMES USD 46.91M 93.61M 2024-03
Alnylam Pharmaceuticals USD -63587000 74.1M 2024-03
Amgen USD -68000000 3.09B 2024-03
Biogen USD 464.8M 336.9M 2024-03
BioMarin Pharmaceutical USD 105.55M 72.22M 2024-03
Cytokinetics USD -135643000 1.25M 2024-03
Dynavax Technologies USD -11497000 12.49M 2024-03
Exelixis USD 49.27M 53.77M 2024-03
Gilead Sciences USD -4486000000 7.08B 2024-03
Halozyme Therapeutics USD 96.03M 26.24M 2024-03
Incyte USD 236.16M 82.99M 2024-03
Intra Cellular Therapies USD -14888000 13.24M 2024-03
Ionis Pharmaceuticals USD -142728000 139.73M 2024-03
Neurocrine Biosciences USD 34.5M 163.7M 2024-03
Pfizer USD 3.42B 4.67B 2024-03
Prothena USD -74440000 3.82M 2024-03
Regeneron Pharmaceuticals USD 700.7M 698.9M 2024-03
Repligen USD 2.11M 21.09M 2024-03
Sarepta Therapeutics USD 41.45M 74.62M 2024-03
Teva Pharmaceutical Industries USD -467000000 974M 2024-03
Ultragenyx Pharmaceutical USD -170229000 43.34M 2024-03
Vertex Pharmaceuticals USD 1.28B 31.7M 2024-03



Neurocrine Biosciences 税前利润 - 当前值，历史数据，预测，统计，图表和经济日历 - Jun 2024.